Press Releases

You Narrowed By: 2012

Showing 71-104 of 104


2012

April

April 19

Abbott Presents Positive Results from Phase 2 "Pilot" Study of an Interferon-Free Combination Regimen for the Treatment of Hepatitis C

April 19

Abbott Presents Positive Results from Interferon-Free Phase 2 "Co-Pilot" Study for the Treatment of Hepatitis C

April 18

Abbott Reports Double-Digit Ongoing Earnings-Per-Share Growth in First Quarter; Raises Full-Year 2012 Outlook

April 17

Abbott Licenses Biomarkers for Use in Differentiating Aggressive from Nonaggressive Prostate Cancer

April 17

Abbott’s Investigational Treatment for Advanced Parkinson’s Disease Demonstrates Positive Results in Phase 3 Clinical Trial

April 11

Abbott's HUMIRA® (adalimumab) Approved in Europe for Treatment of Ulcerative Colitis (UC)

April 9

Abbott Receives Approval for Next-Generation XIENCE PRIME™ Drug Eluting Stent in Japan

April 4

Abbott to Present Positive Phase 2 Results from Multiple Interferon-Free Studies of Combination Regimens for the Treatment of Hepatitis C
 

March

March 30

Abbott's PLEX-ID Molecular System and Tests for Broad Microbial Identification Obtain CE Marking

March 28

Abbott Hosts Conference Call for First-Quarter Earnings

March 21

Abbott Selects AbbVie as New Name for Future Research-Based Pharmaceutical Company

March 20

Abbott Reinforces Global Vascular Leadership with New Data on Innovative Technologies at ACC 2012

March 15

Abbott Announces Patient Enrollment in Two Phase 3 Studies of HUMIRA® (adalimumab) for Moderate to Severe Hidradenitis Suppurativa - (Europe)

March 15

Abbott Announces Patient Enrollment in Two Phase 3 Studies of HUMIRA® (adalimumab) for Moderate to Severe Hidradenitis Suppurativa - (U.S.)

March 12

New Publication Presents Comparative Efficacy Data for Abbott's Zemplar® (paricalcitol) in Treating Secondary Hyperparathyroidism in Hemodialysis Patients

March 8

Abbott's New FreeStyle InsuLinx Blood Glucose Monitoring System Receives FDA Clearance

March 7

Abbott's Absolute Pro® Vascular Self-Expanding Stent System Receives FDA Approval for Treatment of Iliac Artery Disease

March 7

Abbott to Present at Barclays Capital 2012 Global Healthcare Conference

March 6

Abbott and Merck Collaborate to Develop Companion Diagnostic Test for Investigational Cancer Therapy

March 5

Abbott to Collaborate on Rapid Molecular Test to Identify Serious Infections in Bones and Joint

March 2

Abbott's STARLIMS Business Acquires Distribution Partners to Build International Presence

March 1

Abbott to Build Nutrition Manufacturing Facility in Ohio
 

February

February 29

Abbott and Galapagos Announce Global Collaboration for Novel Oral Therapy, GLPG0634, in Phase II to Treat Autoimmune Diseases

February 23

Abbott to Present at Cowen and Company 32nd Annual Health Care Conference

February 23

Abbott Collaborates with Leading U.S. Forensics Center on Human Identification Testing

February 17

Abbott Announces 40th Consecutive Annual Increase in Quarterly Dividend

February 17

Abbott Receives Positive Opinion for HUMIRA® in Ulcerative Colitis from EMA's CHMP

February 13

Study Shows Abbott's Tacrolimus Assay Demonstrates Consistent Organ Transplant Drug Monitoring

February 8

Abbott Creates New Similac SimplySmart™ Baby Bottle with Innovative Features

February 1

Abbott to Present at Leerink Swann 2012 Global Healthcare Conference
 

January

January 30

DNDi and Abbott Expand Partnership to Boost Innovation for Neglected Tropical Diseases

January 25

Abbott Reports Double-Digit Ongoing Earnings-Per-Share Growth in Fourth Quarter and Full-Year 2011

January 18

Abbott’s STARLIMS LIMS Technology to be Installed in FDA Testing Laboratories

January 4

Abbott Hosts Conference Call for Fourth-Quarter and Full-Year 2011 Earnings